These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1939964)
21. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS). Neuhaus KL; von Essen R; Tebbe U; Vogt A; Roth M; Riess M; Niederer W; Forycki F; Wirtzfeld A; Maeurer W J Am Coll Cardiol; 1992 Apr; 19(5):885-91. PubMed ID: 1552106 [TBL] [Abstract][Full Text] [Related]
22. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Collen D Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781 [TBL] [Abstract][Full Text] [Related]
23. [Study of new thrombolytic agents in myocardial infarction: a multicenter randomized trial (APSAC versus rt-PA)]. Cassagnes J; Machecourt J; Bassand JP; Lusson JR; Wolf JE; Anguenot T; Maublant J; Fagret D; Cardot JC Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1593-9. PubMed ID: 1300957 [TBL] [Abstract][Full Text] [Related]
24. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013 [TBL] [Abstract][Full Text] [Related]
28. Thrombolytic therapy in Europe: current status. Vahanian A Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000 [TBL] [Abstract][Full Text] [Related]
29. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
30. Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators. Karagounis LA; Anderson JL; Sorensen SG; Moreno FL Am J Cardiol; 1994 Jan; 73(1):16-22. PubMed ID: 8279371 [TBL] [Abstract][Full Text] [Related]
31. Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators. Anderson JL; Becker LC; Sorensen SG; Karagounis LA; Browne KF; Shah PK; Morris DC; Fintel DJ; Mueller HS; Ross AM J Am Coll Cardiol; 1992 Oct; 20(4):753-66. PubMed ID: 1527286 [TBL] [Abstract][Full Text] [Related]
33. Which thrombolytic agent should one choose? Topol EJ Prog Cardiovasc Dis; 1991; 34(3):165-78. PubMed ID: 1947122 [No Abstract] [Full Text] [Related]
34. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771 [TBL] [Abstract][Full Text] [Related]
36. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
37. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy. Lessler DS; Avins AL Arch Intern Med; 1992 Aug; 152(8):1665-72. PubMed ID: 1497400 [TBL] [Abstract][Full Text] [Related]
38. [Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?]. Gulba DC Internist (Berl); 1992 May; 33(5):364-5. PubMed ID: 1612871 [No Abstract] [Full Text] [Related]
39. Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. Munkvad S; Jespersen J; Gram J; Kluft C J Am Coll Cardiol; 1991 Mar; 17(4):957-62. PubMed ID: 1900313 [TBL] [Abstract][Full Text] [Related]
40. New developments in thrombolytic therapy. Collen D; Gold HK Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]